Cargando…

The way of SARS-CoV-2 vaccine development: success and challenges

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2 vaccines have been developed and several have been allowed for emergency use and rollout worldwide. With novel SARS-CoV-2 variants eme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yetian, Dai, Tong, Wang, Bin, Zhang, Lei, Zeng, Ling-hui, Huang, Jun, Yan, Haiyan, Zhang, Long, Zhou, Fangfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575680/ https://www.ncbi.nlm.nih.gov/pubmed/34753918 http://dx.doi.org/10.1038/s41392-021-00796-w

Ejemplares similares

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

A systematic review of SARS-CoV-2 vaccine candidates
por: Dong, Yetian, et al.
Publicado: (2020)

Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
por: Vashishtha, Vipin M., et al.
Publicado: (2020)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
por: Yu, Sicong, et al.
Publicado: (2021)

SARS-CoV-2 Omicron variant: recent progress and future perspectives
por: Fan, Yao, et al.
Publicado: (2022)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward
por: ISERSON, KENNETH V.
Publicado: (2020)

The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States
por: Dien Bard, Jennifer, et al.
Publicado: (2022)

STING, a critical contributor to SARS-CoV-2 immunopathology
por: Li, Heyu, et al.
Publicado: (2022)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

Challenges and Issues of Anti-SARS-CoV-2 Vaccines
por: Blumental, Sophie, et al.
Publicado: (2021)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
por: Mahboob, Tooba, et al.
Publicado: (2023)

DNA-scaffolded multivalent vaccine against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2023)

A New Way to Trace SARS-CoV-2 Variants Through Weighted Network Analysis of Frequency Trajectories of Mutations
por: Huang, Qiang, et al.
Publicado: (2022)

Challenges and developments in universal vaccine design against SARS-CoV-2 variants
por: Zhao, Fangxin, et al.
Publicado: (2022)

Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
por: Hosseini, Seyede Atefe, et al.
Publicado: (2021)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
por: Wu, Shipo, et al.
Publicado: (2020)

HIV Vaccine Research: The Challenge and the Way Forward
por: Wang, Hai-Bo, et al.
Publicado: (2015)

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
por: Guebre-Xabier, Mimi, et al.
Publicado: (2020)

Ways to Success
Publicado: (1874)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys
por: Jiao, Li, et al.
Publicado: (2021)

Dendrobium officinale aqueous extract influences the immune response following vaccination against SARS-CoV-2
por: Gao, Xiaoping, et al.
Publicado: (2023)

Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China
por: Zhang, Junguo, et al.
Publicado: (2020)

A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
por: Zhang, Mengxin, et al.
Publicado: (2022)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
por: Usmani, Salman Sadullah, et al.
Publicado: (2020)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Current vaccine strategies against SARS-CoV-2: Promises and challenges
por: Kurup, Drishya, et al.
Publicado: (2022)

Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium
por: Su, Peng, et al.
Publicado: (2023)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cgog5mgrncss6n1l6mcmmre0p8